, Vaincre la Mucoviscidose et Institut national d'études démographiques (Ined), 2013.

B. Lubamba, B. Dhooghe, and S. Noel, Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy, Clin Biochem, vol.45, issue.15, pp.1132-1176, 2012.
DOI : 10.1016/j.clinbiochem.2012.05.034

K. A. Ramsey, S. Ranganathan, and J. Park, Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis, Am J Respir Crit Care Med, vol.190, issue.10, pp.1111-1127, 2014.
DOI : 10.1164/rccm.201407-1277oc

URL : https://api.research-repository.uwa.edu.au/files/5127783/Ramsey_2014_CF_longitudinal_spirometry_AJRCCM_R1_clean_FINAL.pdf

J. L. Burns, R. L. Gibson, and S. Mcnamara, Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis, J Infect Dis, vol.183, issue.3, pp.444-52, 2001.

D. Macdonald, L. Cuthbertson, and C. Doherty, Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?, J Antimicrob Chemother, vol.65, issue.11, pp.2373-75, 2010.
DOI : 10.1093/jac/dkq342

URL : https://academic.oup.com/jac/article-pdf/65/11/2373/2304109/dkq342.pdf

L. Yang, L. Jelsbak, and S. Molin, Microbial ecology and adaptation in cystic fibrosis airways, Environ Microbiol, vol.13, issue.7, pp.1682-89, 2011.

N. Mayer-hamblett, M. Rosenfeld, and R. L. Gibson, Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes, Am J Respir Crit Care Med, vol.190, issue.3, pp.289-97, 2014.

A. Rivier, Epidémiologie bactérienne des patients atteints de mucoviscidose suivis au Centre de Ressources et de Compétences de la Mucoviscidose de nancy en 1997 et en, vol.1, 2007.

, Conférence de consensus : Prise en charge du patient atteint de mucoviscidose, Rev Mal Respir, vol.20, pp.149-57, 2003.

G. Döring, S. P. Conway, and H. G. Heijerman, Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus, Eur Respir J, vol.16, issue.4, pp.749-67, 2000.

G. M. Nixon, D. S. Armstrong, and R. Carzino, Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis, J Pediatr, vol.138, issue.5, pp.699-704, 2001.
DOI : 10.1067/mpd.2001.112897

J. Emerson, M. Rosenfeld, and S. Mcnamara, Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis, Pediatr Pulmonol, vol.34, issue.2, pp.91-100, 2002.

P. Schelstraete, F. Haerynck, and S. Van-daele, Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.12, issue.1, pp.1-8, 2013.

L. Hewer, S. C. Smyth, and A. R. , Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis, Cochrane Database of Systematic Reviews, 2014.

P. J. Mogayzel, E. T. Naureckas, and K. A. Robinson, Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection, Ann Am Thorac Soc, vol.11, issue.10, pp.1640-50, 2014.

F. Ratjen, A. Munck, and P. Kho, Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial, Thorax, vol.65, issue.4, pp.286-91, 2010.

T. J. Kidd, K. A. Ramsay, and S. Vidmar, Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.14, issue.3, pp.361-69, 2015.
DOI : 10.1016/j.jcf.2014.12.007

URL : https://doi.org/10.1016/j.jcf.2014.12.007

N. H. Renders, M. A. Sijmons, and A. Van-belkum, Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings, Res Microbiol, vol.148, issue.5, pp.447-54, 1997.
DOI : 10.1016/s0923-2508(97)83875-2

L. D. Knibbs, G. R. Johnson, and T. J. Kidd, Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis, Thorax, vol.69, issue.8, pp.740-785, 2014.

P. Schelstraete, S. Van-daele, D. Boeck, and K. , Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients, Eur Respir J, vol.31, issue.4, pp.822-851, 2008.

M. E. Purdy-gibson, M. France, and T. C. Hundley, Pseudomonas aeruginosa in CF and non-CF homes is found predominantly in drains, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.14, issue.3, pp.341-387, 2015.

S. C. Ranganathan, B. Skoric, and K. A. Ramsay, Geographical Differences in First Acquisition of Pseudomonas aeruginosa in Cystic Fibrosis, Ann Am Thorac Soc, vol.10, issue.2, pp.108-122, 2013.

J. Zimakoff, N. Hoiby, and K. Rosendal, Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic, J Hosp Infect, vol.4, issue.1, pp.31-40, 1983.

Y. F. Berrouane, L. A. Mcnutt, and B. J. Buschelman, Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.31, issue.6, pp.1331-1368, 2000.

E. T. Jensen, B. Giwercman, and B. Ojeniyi, Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment, J Hosp Infect, vol.36, issue.2, pp.117-139, 1997.

D. P. Speert and M. E. Campbell, Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis, J Hosp Infect, vol.9, issue.1, pp.11-21, 1987.
DOI : 10.1016/0195-6701(87)90089-2

K. Psoter, A. De-roos, and J. Mayer, Fine Particulate Matter Exposure and Initial Pseudomonas aeruginosa Acquisition in Cystic Fibrosis, Ann Am Thorac Soc, vol.12, issue.3, pp.385-91, 2015.

P. C. Goeminne, T. S. Nawrot, D. Boeck, and K. , Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case-control analysis, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.14, issue.6, pp.741-788, 2015.

K. J. Psoter, A. J. De-roos, and J. Wakefield, Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.19, issue.11, pp.483-89, 2013.

J. M. Collaco, J. Mcgready, and D. M. Green, Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study, PloS One, vol.6, issue.11, pp.277-84, 2011.

K. J. Psoter, M. Rosenfeld, D. Roos, and A. J. , Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis, Am J Epidemiol, vol.179, issue.12, pp.1503-1516, 2014.

J. H. Maselli, M. K. Sontag, and J. M. Norris, Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening, Pediatr Pulmonol, vol.35, issue.4, pp.257-62, 2003.

E. Kerem, M. Corey, and R. Stein, Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients, Pediatr Infect Dis J, vol.9, issue.7, pp.494-98, 1990.

J. M. Collaco, C. B. Morrow, and D. M. Green, Environmental allergies and respiratory morbidities in cystic fibrosis, Pediatr Pulmonol, vol.48, issue.9, pp.857-64, 2013.

M. Rosenfeld, J. Emerson, and S. Mcnamara, Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.11, issue.5, pp.446-53, 2012.

C. B. Morrow, K. S. Raraigh, and D. M. Green, Cat and dog exposure and respiratory morbidities in cystic fibrosis, J Pediatr, vol.165, issue.4, pp.830-865, 2014.

D. M. Green, J. M. Collaco, and K. E. Mcdougal, Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis, J Pediatr, vol.161, issue.2, pp.290-95, 2012.

, Association française pour le dépistage et la prévention des handicaps de l'enfant. Organisation du programme de dépistage néonatal de la mucoviscidose, 2001.

D. Boeck, K. Wilschanski, M. Castellani, and C. , Cystic fibrosis: terminology and diagnostic algorithms, Thorax, vol.61, issue.7, pp.627-662, 2006.

P. Stafler, J. C. Davies, and I. M. Balfour-lynn, Bronchoscopy in cystic fibrosis infants diagnosed by newborn screening, Pediatr Pulmonol, vol.46, issue.7, pp.696-700, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00618191

A. Avital, K. Uwyyed, and E. Picard, Sensitivity and specificity of oropharyngeal suction versus bronchoalveolar lavage in identifying respiratory tract pathogens in children with chronic pulmonary infection, Pediatr Pulmonol, vol.20, issue.1, pp.40-43, 1995.

M. Rosenfeld, J. Emerson, and F. Accurso, Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis, Pediatr Pulmonol, vol.28, issue.5, pp.321-349, 1999.

, Météo France Lorraine disponible sur www.meteofrance

T. H. Turnovska and B. I. Marinov, The influence of air pollution during intrauterine development and early childhood on respiratory functions at later age, Int J Hyg Environ Health, vol.212, issue.5, pp.519-551, 2009.

S. Stick, Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease, Thorax, vol.55, issue.7, pp.587-94, 2000.

K. E. Pinkerton and J. P. Joad, Influence of air pollution on respiratory health during perinatal development, Clin Exp Pharmacol Physiol, vol.33, issue.3, pp.269-72, 2006.

M. B. Rice, S. L. Rifas-shiman, and A. A. Litonjua, Lifetime Exposure to Ambient Pollution and Lung Function in Children, Am J Respir Crit Care Med, vol.193, issue.8, pp.881-88, 2015.

E. S. Schultz, J. Hallberg, and T. Bellander, Early-Life Exposure to Traffic-related Air Pollution and Lung Function in Adolescence, Am J Respir Crit Care Med, vol.193, issue.2, pp.171-77, 2016.

C. H. Goss, S. A. Newsom, and J. S. Schildcrout, Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis, Am J Respir Crit Care Med, vol.169, issue.7, pp.816-837, 2004.

J. M. Collaco, L. Vanscoy, and L. Bremer, Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease, JAMA, vol.299, issue.4, pp.417-441, 2008.

T. A. Douglas, S. Brennan, and S. Gard, Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis, Eur Respir J, vol.33, issue.2, pp.305-316, 2009.

P. M. Farrell, Z. Li, and M. R. Kosorok, Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis, Am J Respir Crit Care Med, vol.168, issue.9, pp.1100-1108, 2003.

D. Hayes, S. E. West, and M. J. Rock, Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes, Pediatr Pulmonol, vol.45, issue.7, pp.708-724, 2010.

J. D. Chalmers, G. B. Fleming, and A. T. Hill, Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis, Glycobiology, vol.21, issue.3, pp.271-82, 2011.

M. L. Drumm, M. W. Konstan, and M. D. Schluchter, Genetic modifiers of lung disease in cystic fibrosis, N Engl J Med, vol.353, issue.14, pp.1443-53, 2005.

M. S. Schechter, S. A. Mccolley, and S. Silva, Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis, J Pediatr, vol.155, issue.5, pp.634-673, 2009.

J. M. Collaco, S. M. Blackman, and J. Mcgready, Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function, J Pediatr, vol.157, issue.5, pp.802-809, 2010.

G. Taccetti, E. Bianchini, and L. Cariani, Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols, Thorax, vol.67, issue.10, pp.853-59, 2012.

H. K. Johansen and P. C. Gøtzsche, Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis, REGLEMENTATION CONCERNANT LA POLLUTION ? Valeurs recommandées selon l'OMS, vol.8, 2015.
DOI : 10.1002/14651858.cd001399.pub3

, Le droit français concernant la qualité de l'air est fondée sur la loi n°96-1236 du 30 décembre 1996 sur l'air et l'utilisation rationnelle de l'énergie (LAURE) condifiée dans le code de l'environnement. Cette loi s'appuie sur le "droit reconnu à chacun de respirer un air qui ne nuise pas à sa santé

. , juillet 2010 portant engagement national pour l'environnement

, Code de l'Environnement version consolidée au 17 novembre 2014 : la loi LAURE a été intégrée au code de l'environnement Livre II Titre II ? Directives européennes

, Des directives européennes sont à l'origine de la réglementation française pour l'air ambiant, qui déterminent des seuils à ne pas dépasser pour une vingtaine de polluants en fonction de leur impact sur la santé humaine

, La réglementation européenne est basée sur les directives suivantes : Directive 2008/50/CE du Parlement Européen et du Conseil du 21 mai 2008 concernant la qualité de l'air ambiant et un air pur pour l'Europe